Spirits maker Diageo removes medium-term guidance on U.S. tariff uncertainty

Spirits maker Diageo removes medium-term guidance on U.S. tariff uncertainty


Bottles of Diageo-owned Johnnie Walker Red Label whisky in a supermarket in Chelmsford, UK, on Tuesday, Jan. 28, 2025. 

Bloomberg | Getty Images

Spirits maker Diageo said Tuesday that it is taking steps to deal with the potential impact of U.S. tariffs on key supply chain regions and has removed its medium-term guidance due to macroeconomic and geopolitical uncertainty.

CEO Debra Crew said the prospect of tariffs could hamper the firm’s efforts to recover falling sales and that it had added “further complexity” to its ability to provide updated guidance.

Diageo had previously forecast medium-term organic sales growth of between 5% and 7%.

“We are taking a number of actions to mitigate the impact and disruption to our business that tariffs may cause, and we will also continue to engage with the U.S. administration on the broader impact that this will have on everyone supporting the U.S. hospitality industry, including consumers, employees, distributors, restaurants, bars and other retail outlets,” Crew said in a statement accompanying the firm’s interim earnings.

In a Tuesday earnings call, Chief Financial Officer Nik Jhangiani said that the implementation of U.S. tariffs was expected and that the firm was taking and would continue to implement a number of actions to mitigate the impact. Such measures include pricing strategies, inventory management, supply chain adaptation and reallocation of investment.

Further updates will be provided when management can “more accurately forecast the financial impact of tariffs,” he added.

The FTSE 100-listed company posted a 0.6% decline in first-half reported sales to $10.9 billion, coming in slightly ahead of the $10.7 billion estimated by analysts in an LSEG poll.

Spirits brands including Tanqueray, Gordon’s and Smirnoff saw the steepest declines in net sales, while Guinness was a clear outlier, posting double-digit growth for an eighth consecutive half-year period.

The drinks maker has come under pressure from investors amid falling sales, management changes, the rise of weight-loss drugs — which may be able to reduce alcohol consumption — and a broader trend toward low- and no-alcohol products.

Shares of Diageo — whose brands include Johnnie Walker, Captain Morgan and Don Julio — fell 3% Monday amid a wider global sell-off, as investors assessed the economic impact of Trump’s tariffs on imports from Canada, Mexico and China.

Almost half (46.2%) of Diageo’s U.S. sales are derived from imports from Mexico and Canada, including brands such as Crown Royal, Don Julio and Casamigos, Jefferies analysts estimated in a note Sunday.

That compares to the just over one-third (35.3%) of U.S. sales imported from Mexico and Canada for Italy’s Campari Group and the 6% equivalent for France’s Pernod Ricard.

As such, Diageo could be expected to hike prices for U.S. consumers by around 4.6% — and that’s before any possible new tariffs on EU goods, the analysts said.

Stock Chart IconStock chart icon

hide content

Diageo.

In 2024, Diageo reported its first drop in global sales since the start of 2020. Sales fell 1.4% to $20.3 billion in the year ended June. It followed a prior profit warning in November 2023 which showed declining sales in Latin America, the Caribbean and the U.S.

Diageo shares are currently languishing near pandemic-era lows, despite briefly climbing last month on reports that it was it was considering the sale of its Guinness beer brand — a top performer in the group’s portfolio — or its stake in LVMH‘s drinks unit Moet Hennessy.

In a statement released Jan. 26, the firm said it had “no intention to sell either,” sending the stock lower again.



Source

Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’
World

Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’

Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult situation” and the reality will soon catch up with both drugmakers and patients. “The longer-term implications are significant,” CEO Vas Narasimhan told CNBC’s Carolin Roth. Novartis is focused on getting European and Japanese governments to quickly change […]

Read More
CNBC Daily Open: Hawkish hold from BOJ sets central bank stage
World

CNBC Daily Open: Hawkish hold from BOJ sets central bank stage

The Bank of Japan headquarters in Tokyo on May 30, 2024. Kazuhiro Nogi | Afp | Getty Images Hello, this is Katie Foley writing to you from London. I spend my mornings leading the London TV teams as we prepare to take Europe Early Edition and Squawk Box Europe to air. Over the last two […]

Read More
European markets to open higher as Trump considers Iran peace proposal
World

European markets to open higher as Trump considers Iran peace proposal

LONDON — European stocks are expected to open higher on Tuesday as investors await Washington’s response to Iranian peace proposals and look ahead to earnings reports from several regional companies. The U.K.’s FTSE 100 index is seen opening a touch higher, with Germany’s DAX up 0.23%, France’s CAC 40 up 0.34% and Italy’s FTSE MIB 0.3% […]

Read More